Device / Technology News

RSS

BSGI proves to be an effective adjunct imaging modality for detecting DCIS

Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the detection of ductal carcinoma in situ (DCIS), a difficult to diagnose breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers.

30 Nov 2009

ADS partners with CDP Medical for leading edge PACS solutions

Advanced Data Systems Corporation (ADS), a leader in Radiology information systems with its MedicsRIS for Radiology is proud to announce its partnership with CDP Medical for leading edge PACS solutions.

30 Nov 2009

Biomagnetics Diagnostics announces Patent License Agreement with Los Alamos National Security

Biomagnetics Diagnostics Corp. (PINK SHEETS:BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the Company has finalized a "Patent License Agreement with Los Alamos National Security."

30 Nov 2009

Clinical trials of personalised vaccines to fight glioblastomas

The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines —produced from healthy and tumour cells from the patient him or herself— and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.

30 Nov 2009

Global CRO PRA International achieves Rave Accredited Plus status in the ASPire to Win program

Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that PRA International, a global clinical research organization (CRO), has achieved Rave Accredited Plus status in the ASPire to Win® program for CROs and other service providers.

30 Nov 2009

Applied Spine Technologies awarded U.S patent relating to mounting mechanisms for pedicle screws

Applied Spine Technologies, Inc., a medical device company focused on motion preservation of the lumbar spine, has been awarded a new patent titled "Mounting mechanisms for pedicle screws and related assemblies”.

30 Nov 2009

DALSA launches its XRI-1600 digital image processor at the RSNA 2009

DALSA, a global leader in digital imaging technology, today announced the introduction of its XRI-1600 digital image processor, which is ideal for X-ray imaging applications. At RSNA 2009, the annual meeting of the Radiological Society of North America held at McCormick Place in Chicago, DALSA will be demonstrating the XRI-1600 at Booth #7117 (North Building, Hall B) from November 29 - December 4, 2009.

30 Nov 2009

Sanofi-aventis, Intelliject sign an exclusive licensing agreement for novel epinephrine auto injector

Sanofi-aventis U.S. announced today the signing of an exclusive licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis) in North America (U.S. and Canada).

30 Nov 2009

MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy

MagForce Nanotechnologies AG has submitted the product file for NanoTherm® to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. With this step, MagForce has now commenced the conformity assessment procedure for its Nano-Cancer ® therapy.

30 Nov 2009

Xencor licenses its XmAb and Xtend technology platforms to Centocor Research & Development

Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation and biosuperior antibodies, announced today that it has licensed its XmAb® and Xtend™ technology platforms to Centocor Research & Development, Inc. for the optimization of Centocor’s antibody drug candidates.

30 Nov 2009

DALSA to showcase its Helios10 MD panel at the RSNA 2009

DALSA Corporation, through its Rad-icon Imaging division, today announced general availability of the Helios10 MD panel, the first product in the company's new Helios camera family. With an active area of 20 x 25 cm, the Helios10 MD is the first CMOS X-Ray panel from DALSA of this size and form factor, a medical-grade cassette package with an integrated handle.

30 Nov 2009

Acsys Interactive's recommendations to the FDA on social media in the healthcare industry

At the invitation of the Food and Drug Administration, Stan Valencis, President of Acsys Interactive, recently presented a series of recommendations to help shape the government's policy towards the promotion of prescription drugs, biologics and medical devices using the Internet and social media tools. As a leader in providing digital marketing and interactive strategies to healthcare systems, hospitals, device manufacturers and pharmaceutical companies, Acsys Interactive was selected by the FDA to provide its uniquely qualified perspective and experience.

30 Nov 2009

MHI team performs catheter implantation of the new Amptlazer Cardiac Plug prosthesis

A multidisciplinary team from the Montreal Heart Institute (MHI) performed its first catheter implantation of a new prosthesis (Amptlazer(R) Cardiac Plug) closing the appendage of the left atrium of the heart, which will have the effect of preventing the formation of blood clots and avoiding open-heart surgery. This is excellent news for patients suffering from atrial fibrillation, the most common form of cardiac arrhythmia, affecting at least 5% of Canadians over the age of 70.

30 Nov 2009

Covidien sells its Oxygen Therapy product line to Chart Industries

Covidien, a leading global provider of healthcare products, today announced that it had completed the previously announced sale of its Oxygen Therapy assets to Chart Industries, Inc.. Financial terms of the transaction were not disclosed.

From Chart Industries 30 Nov 2009

Presentations at Tuesday's RSNA conference

A new study from Cincinnati Children's Hospital Medical Center reports that beverage can stay-tabs pose a potential ingestion risk. In the 1970s, U.S. manufacturers switched to the stay-tab design after safety concerns about pull-tabs. The new study found 19 cases of stay-tab ingestion at a single institution, mainly among teenagers.

30 Nov 2009

Neurotechnology releases upgraded multi-biometric and AFIS systems

Neurotechnology, a provider of high-precision biometric identification technologies, has released two new upgrades in the company's core product line: VeriLook 4.0 Software Development Kit (SDK) for facial recognition and MegaMatcher 3.1 SDK for large-scale multi-biometric and automated fingerprint identification systems (AFIS). Expanded capabilities in VeriLook 4.0 provide enhanced facial recognition reliability across a wider range of facial positions.

30 Nov 2009

Medipattern, Sentinelle Medical sign technology access and distribution agreement

The Medipattern Corporation (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity and Sentinelle Medical Inc., a leading manufacturer of magnetic resonance imaging (MRI) coils and advanced visualization software, have announced that they are entering a technology access and distribution agreement.

30 Nov 2009

Cardiac Science, eClinicalWorks announce partnership

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices that connect to electronic medical record (EMR) and hospital information systems, today announced a partnership with eClinicalWorks, a leading provider of EMR systems.

30 Nov 2009

Sentinelle Medical, Siemens Healthcare to jointly develop solutions for Interventional Prostate MRI

Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and software, and Siemens Healthcare today announced at the Radiological Society of North America (RSNA) annual meeting in Chicago, that they are collaborating on the development of a suite of innovative solutions for Interventional Prostate MRI.

30 Nov 2009

Minerva Biotechnologies grants Clarient exclusive commercializing rights to its MUC1 diagnostic test

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that privately held, Waltham, MA-based Minerva Biotechnologies has granted it the exclusive right to develop and commercialize a test that identifies the MUC1* protein, a biomarker researchers believe may be implicated in the spread of many cancers, including breast cancer.

30 Nov 2009

Device / Technology News

BSGI proves to be an effective adjunct imaging modality for detecting DCIS

ADS partners with CDP Medical for leading edge PACS solutions

Biomagnetics Diagnostics announces Patent License Agreement with Los Alamos National Security

Clinical trials of personalised vaccines to fight glioblastomas

Global CRO PRA International achieves Rave Accredited Plus status in the ASPire to Win program

Applied Spine Technologies awarded U.S patent relating to mounting mechanisms for pedicle screws

DALSA launches its XRI-1600 digital image processor at the RSNA 2009

Sanofi-aventis, Intelliject sign an exclusive licensing agreement for novel epinephrine auto injector

MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy

Xencor licenses its XmAb and Xtend technology platforms to Centocor Research & Development

DALSA to showcase its Helios10 MD panel at the RSNA 2009

Acsys Interactive's recommendations to the FDA on social media in the healthcare industry

MHI team performs catheter implantation of the new Amptlazer Cardiac Plug prosthesis

Covidien sells its Oxygen Therapy product line to Chart Industries

Presentations at Tuesday's RSNA conference

Neurotechnology releases upgraded multi-biometric and AFIS systems

Medipattern, Sentinelle Medical sign technology access and distribution agreement

Cardiac Science, eClinicalWorks announce partnership

Sentinelle Medical, Siemens Healthcare to jointly develop solutions for Interventional Prostate MRI

Minerva Biotechnologies grants Clarient exclusive commercializing rights to its MUC1 diagnostic test

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News